Engflag
Advertisements

Pantoc 40 mg

Quick links to important sections

Pantoc 40 mg

Selected form

Pantoc 40 mg_EN
Advertisements
Advertisements

Method of action: Antiulcer, Drugs For Acid Related Disorders, Proton Pump Inhibitor

Treatment option: Gastroesophageal Reflux Disease, Hypersecretory Conditions, Heartburn, Pathological Hypersecretory Conditions, Reflux, Zollinger-Ellison Syndrome, Esophagitis, Erosive Esophagitis

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Pantoc 40 mg

What is Pantoc 40 mg? Identity and General Purpose

Property Description
Active ingredient Pantoprazole (as sodium sesquihydrate)
Form Gastro-resistant tablet (Delayed-release oral tablet)
Pharmacological class Proton Pump Inhibitor (PPI)
Common use Reducing stomach acid secretion
Origin Synthetic (Substituted benzimidazole derivative)

Defining Pantoc 40 mg: Identity and Pharmacological Class

Pantoc 40 mg is a prescription-only (Rx), synthetic medicine utilizing the active substance Pantoprazole (INN). It is scientifically classified as a Proton Pump Inhibitor (PPI), a designation that is clinically recognized for its superior acid control compared to older receptor-blocking agents. Pantoprazole is a substituted benzimidazole derivative. This medication is specifically positioned within the acid-control category to manage conditions where powerful, sustained reduction of gastric acid is required. The 40 mg strength defines the precise quantity of active ingredient present in each tablet.

Composition, Form, and General Therapeutic Purpose

The preparation uses Pantoprazole sodium sesquihydrate and is administered orally as a gastro-resistant tablet (delayed-release oral tablet). This specialized coating is structurally integral to the medication, ensuring the acid-sensitive Pantoprazole is protected from degradation by stomach acid before reaching the small intestine for absorption. The gastro-resistant form is therefore a key element of the drug's reliable functionality. PPIs like Pantoprazole are fundamental for achieving a prolonged reduction in gastric acid output, thereby providing continuous relief from discomfort and aiding the natural repair of tissues irritated by chronic exposure to excess acid.

Regulatory References

  1. U.S. National Library of Medicine
Advertisements

What side effects are possible with Pantoc 40 mg?

Pantoc (pantoprazole) 40 mg is generally well-tolerated, with side effects often mild and transient.

Common Side Effects

Side effects that commonly occur include headache, diarrhea, nausea, vomiting, abdominal pain, flatulence (gas), and dizziness. If these symptoms become severe or persistent, patients should consult their doctor.

Serious and Long-Term Safety Information

While rare, Pantoc can be associated with more serious adverse events. Immediate medical attention is required if signs of a severe allergic reaction occur, such as swelling of the face, lips, tongue, or throat, or difficulty breathing.

Long-Term Use Risks

Extended use of pantoprazole (typically over a year, or sometimes over three months) has been linked to potential risks, including:

  • Bone Fractures: An increased risk of fractures of the hip, wrist, or spine, particularly in older adults or those on high doses.
  • Low Magnesium Levels (Hypomagnesemia): Symptoms may include fatigue, muscle spasms, convulsions, and irregular heartbeat.
  • Vitamin B12 Deficiency: Long-term reduction of stomach acid can reduce the absorption of Vitamin B12, potentially leading to anemia and neurological symptoms.
  • Kidney Problems: Rare cases of acute interstitial nephritis (a form of kidney inflammation) have been reported.
  • Severe Diarrhea: Increased risk of Clostridioides difficile-associated diarrhea (CDAD).

Patients taking Pantoc for prolonged periods should be regularly monitored by a healthcare provider. Patients must not stop taking the medication abruptly without consulting a doctor, as this may lead to a rebound increase in acid production.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory information for Pantoc 40 mg (pantoprazole) indicates that human experience with overdose is limited. Specific symptoms of overdose are not consistently documented in man, and spontaneous post-marketing reports of overdose generally involve effects that are already known from the standard safety profile, such as gastrointestinal upset or central nervous system effects.

Regulatory documents emphasize that even with high doses, up to 240 mg administered intravenously, the substance has been reported as well tolerated in clinical settings, but experience with even larger amounts is scarce.

Immediate Medical Action Required

Always contact a healthcare professional, hospital emergency department, or regional Poison Control Centre immediately, even if the individual has no noticeable symptoms.

Because Pantoc is extensively bound to plasma proteins, it is not readily removed from the body using hemodialysis (an external blood filtering procedure).

In the event of an overdose with clinical signs of intoxication, the recommended course of action is symptomatic and supportive treatment, as there are no specific therapeutic recommendations known for pantoprazole overdose.

Official Overdose Summary

Overdose Factor Official Regulatory Statement
Symptom Profile No specific symptoms of overdose are known in man.
Highest Reported Dose Doses up to 240 mg have been reported as well tolerated.
Emergency Treatment Symptomatic and supportive treatment; no specific antidote.
Dialysis Efficacy Not removed by hemodialysis due to extensive protein binding.
Advertisements

Therapeutic Uses of Pantoc 40 mg

Quick Facts: Therapeutic Domains

  • Erosive Esophagitis (EE): Used for the short-term management and healing of damage to the esophagus lining.
  • Gastroesophageal Reflux Disease (GERD): Indicated for the maintenance of healing of EE associated with GERD, aiming to reduce the relapse rate of symptoms.
  • Hypersecretory Conditions: Appropriate for the long-term management of conditions where the stomach produces an excess of acid, such as Zollinger-Ellison Syndrome.

Pantoc 40 mg is used to manage specific conditions where a reduction of gastric acid is necessary. The primary therapeutic uses include the short-term treatment and healing of erosive esophagitis, which involves damage to the esophagus caused by acid reflux. The medication may also be used for the long-term maintenance of healing of this damage in adult patients with Gastroesophageal Reflux Disease (GERD).

Furthermore, Pantoc 40 mg is indicated for the long-term management of pathological hypersecretory conditions, including Zollinger-Ellison Syndrome. These conditions involve the stomach producing an excessive quantity of acid. Use of this medication in these domains aims to support the healing process and provide symptomatic relief associated with these disorders. This approach is intended to provide effective clinical support for these acid-related disorders.

Advertisements

Eligibility and Restrictions for Use

This information details the officially documented eligibility and non-eligibility rules for Pantoc 40 mg, as established by governmental regulatory agencies.

Eligibility Domain Regulatory Constraint or Exclusion
Known Hypersensitivity The medicine is contraindicated in patients with a known allergy to the active substance (pantoprazole), any other components of the formulation, or substituted benzimidazoles.
Concomitant Drug Use The medicine is contraindicated for use in patients receiving rilpivirine-containing products. Co-administration with atazanavir or nelfinavir is also not recommended.
Age and Development Use is established for adults. For certain indications, adolescents 12 years of age and older are eligible (EMA context), and pediatric patients 5 years of age and older (FDA context) may be eligible for specific short-term treatments. Use is not recommended in children younger than 12 years (EMA context) or for uses other than those specifically established in children.
Severe Hepatic Impairment For patients with severe liver impairment, the daily dose of 40 mg is restricted and generally should not be exceeded; its use in combination therapy for H. pylori eradication is not recommended in this population.
Pregnancy/Lactation Use during pregnancy is generally not recommended unless considered clearly necessary. The medicine is not recommended for use during breastfeeding as the substance/metabolites are excreted in human milk.

These official statements define who may and who must not use the medicine, establishing absolute contraindications based on hypersensitivity or concurrent medication, and specifying restrictions related to a patient’s age or the severity of their liver function.

Advertisements

What should I know about interactions with other medicines?

Pantoprazole (the active ingredient in Pantoc 40 mg) can affect the absorption of other medications due to its strong acid-reducing effect in the stomach. This reduced acidity can be particularly problematic for drugs that require an acidic environment to be absorbed properly into the body.

Before starting Pantoc 40 mg, it is essential to inform your healthcare provider about all prescription, over-the-counter medicines, and supplements you are currently taking.

Key Drug Interactions to Note

Drug Class Example Medications Potential Effect
Antiretrovirals Rilpivirine, Atazanavir Significantly decreased effectiveness of the antiviral medication. Co-administration with rilpivirine is generally not recommended.
Anticoagulants Warfarin Increased risk of bleeding; close monitoring of blood coagulation parameters (INR) may be required.
Methotrexate High-dose Methotrexate Increased and prolonged levels of methotrexate in the blood, potentially leading to toxicity.
Iron Supplements Oral Iron Reduced iron absorption, making the supplement less effective.
Certain Antifungals Itraconazole, Ketoconazole Reduced absorption of the antifungal, leading to decreased effectiveness.

Additionally, long-term use of Pantoc 40 mg may interfere with the absorption of essential micronutrients, such as Vitamin B12 and magnesium. Close monitoring may be necessary during extended treatment. You should also inform your doctor if you have a history of liver disease or osteoporosis, as Pantoc may worsen these conditions.

Advertisements

Mechanism of Action

Direct Inhibition of the Gastric Proton Pump

Pantoprazole, the active agent in Pantoc, is a proton pump inhibitor (PPI) that functions as a prodrug. It accumulates selectively within the highly acidic secretory canaliculi of the stomach's parietal cells. Under this acidic condition, the prodrug is converted into its active form, a sulfenamide, which then engages its molecular target

.

Mechanism of Irreversible Enzyme Binding

Once activated, pantoprazole covalently and irreversibly binds to specific sulfhydryl groups on the H^+/ K^+-ATPase enzyme system, commonly known as the proton pump. This enzyme is responsible for the final stage of acid production: the exchange of hydrogen ions ( H^+) for potassium ions ( K^+) across the apical membrane. By binding to this enzyme, pantoprazole establishes a blockade of the H^+ ion translocation.

System-Level Antisecretory Effect

This specific molecular inhibition leads to a profound suppression of both basal and stimulated gastric acid secretion. Because the enzyme binding is irreversible, the anti-secretory effect persists until the parietal cell synthesizes and inserts new H^+/ K^+-ATPase pumps into its membrane, which dictates the long duration of the drug's physiological action.

Advertisements

Dosage and Administration Information

Pantoc (pantoprazole sodium) is a delayed-release tablet prescribed to reduce stomach acid production. It is a proton pump inhibitor primarily used for conditions such as Erosive Esophagitis (EE) associated with Gastroesophageal Reflux Disease (GERD) and Pathological Hypersecretory Conditions, including Zollinger-Ellison Syndrome. You must take this medication exactly as directed by your healthcare provider, using the lowest dose for the shortest duration necessary to treat your condition.

Administration Guidelines

Condition Typical Adult Dosage Administration Detail
Erosive Esophagitis 40 mg once daily Take with or without food. Duration is typically up to 8 weeks.
Zollinger-Ellison Syndrome 40 mg twice daily Initial dosage may be adjusted by your doctor based on acid output measurements.

Important Instructions

  • Swallow Whole: The delayed-release tablets must be swallowed whole. Do not split, crush, or chew the tablet, as this will damage the enteric coating and may alter the medication’s effect and increase side effects.
  • Consistency: Take the tablet at approximately the same time each day.
  • Missed Dose: If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and continue your regular dosing schedule. Do not take two doses at once to make up for a missed dose.
  • Duration: Continue taking the medication for the full prescribed length of time, even if symptoms improve quickly. Consult your healthcare provider if symptoms do not improve or worsen during treatment.

Note: If you are unable to swallow the 40 mg tablet, consult your doctor about the possibility of taking two 20 mg tablets instead, or using an alternative formulation.

Advertisements

Recent Clinical Evidence

Pantoc 40 mg: Recent Clinical Evidence

Pantoc 40 mg, containing the active substance pantoprazole, is a proton pump inhibitor (PPI) that has been the subject of numerous clinical trials for acid-related disorders. The research evidence primarily centers on its use for Gastroesophageal Reflux Disease (GERD) and the healing and maintenance of erosive esophagitis (EE).

Efficacy in Esophagitis and Symptom Relief

Clinical studies, including randomized, controlled trials, have investigated the outcomes of treatment with pantoprazole 40 mg. Key findings include:

  • Erosive Esophagitis Healing: Multiple short-term studies, typically spanning 4 to 8 weeks, observed that treatment with pantoprazole 40 mg was associated with high rates of esophageal mucosal healing. Healing rates of 70% to 88% after eight weeks have been documented in various populations, a higher incidence compared to placebo and certain histamine-2 receptor antagonists (H2RAs).
  • Symptom Resolution: Trial data indicate that patients administered pantoprazole 40 mg often reported a reduction in reflux-related symptoms, such as heartburn and acid regurgitation. Significant symptomatic improvement was noted within the first days to the first week of treatment in many participants.
  • Maintenance of Healing: Long-term studies, some extending for up to three years, explored the use of pantoprazole 40 mg for preventing the relapse of healed erosive esophagitis. These trials suggest that continued treatment may be associated with maintaining remission in a substantial percentage of patients.

Comparative and Safety Profiles

Comparative trials generally suggest that pantoprazole 40 mg has efficacy similar to that of other leading proton pump inhibitors (PPIs) when used for the initial treatment of GERD and EE. Regarding safety, pantoprazole has been reported in clinical settings to be generally well-tolerated across the study duration in both adult and pediatric populations (aged 5 years and older).

However, it is established through collective evidence that the long-term use of PPIs, including pantoprazole, has been associated in observational studies with potential risks such as nutritional deficiencies (e.g., Vitamin B12 and magnesium) and an increased fracture risk, particularly in elderly patients receiving high doses for extended periods.

Advertisements

How should Pantoc 40 mg be stored and disposed of?

How to Store and Dispose of Pantoc 40 mg?

This section details the official, mandatory requirements for the storage and disposal of Pantoc 40 mg (pantoprazole delayed-release tablets), as outlined in regulatory prescribing information.

Official Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Protection Must be kept protected from moisture and direct light.
Container Keep in the original container and ensure it is tightly closed.
Freezing Do not freeze the medication.
Stability If supplied in a bottle, use within 3 months of the first opening.
Child Safety Keep out of the sight and reach of children.

Official Disposal Instructions

Discarded or expired Pantoc 40 mg must be handled according to strict regulatory guidelines. Do not dispose of the tablets via household waste or wastewater.

Any unused medicine or waste material must be disposed of in accordance with local and national regulations. Consult a pharmacist or healthcare professional for instructions on proper drug disposal in your area.

Advertisements

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagPortugal

Equivalent of Pantoc 40 mg found in:

A-Z Index: